Despite B-cell depletion, ppl w/ MS mount good T cell responses after the COVID vaccine. Check it out in our recent paper! Thanks to amazing co-authors Pavan Bhargava, @marialreyesman1, Kate Fitzgerald, Ellen Mowry, Peter Calabresi authors.elsevier.com/sd/article/S23…
What a great opportunity to review neuroanatomy today sectioning a brain for MS research 🧠 #neuroanatomy #multipleslcerosis #MSresearch Peter Calabresi Sachin Gadani
So excited to share this labor of love with the world! Our latest paper from the Peter Calabresi lab is out now on eLife and the immunologists and neuroscientists alike are gonna love it 🧵elifesciences.org/articles/82938
Check this out!🛑In this review, we describe the animal models that recapitulate the inflammatory microenvironment of the CNS and have provided insight into the mechanisms underlying the failure of remyelination in MS.
Peter Calabresi
frontiersin.org/articles/10.33…
A huge Congratulations to all Giants in Multiple Sclerosis 🎆! Congrats Dr. Peter Calabresi Peter Calabresi from Johns Hopkins!👏 ❤️
globenewswire.com/en/news-releas…
Blessed to call Kathryn Fitzgerald my mentor! We had fun at the Johns Hopkins Medicine Precision Medicine Symposium where amongst others, our MS Center leaders discussed the advantages and possibilities of precision medicine as a research and clinical tool. Ellen Mowry Peter Calabresi
Thrilled to be part of today's #ANA2020 American Neurological Association Plenary Session on 'Targeting Glia for Therapy'. Together with Peter Calabresi Erin Gibson Jessica Sadick and Supriya Ramesha. Chaired by Jenn Orthmann Murphy and Timothy Greenamyre. Join us at 4:30 PM EDT. Don't miss it!!!
Happy to share that our paper on new markers of a neurotoxic, reactive astrocyte sub-state is out! Huge thanks to Junmin Peng, Peter Calabresi, Shane Liddelow 🍊, and most of all VFossati (she, her) and New York Stem Cell Foundation Research Institute who made this possible. A 🧵. frontiersin.org/articles/10.33…
A diagram looking at potential remyelinating therapies for MS from an excellent article in Elsevier. Authors: Peter Calabresi Riley Catenacci Marjan Gharagozloo pubmed.ncbi.nlm.nih.gov/35255453/
Kenneth P Johnson Memorial Lecture by Peter Calabresi Peter Calabresi at ACTRIMS® #ACTRIMS2020 #MultipleSclerosis
Our review of the role of B cells in cortical demyelination is now out in Brain . A fruitful collaboration with Hans-Peter Hartung and Peter Calabresi
Our latest collaborative study demonstrating prominent changes in AAA metabolism which are also related to MS disease severity. With Kathryn Fitzgerald shailendra giri Peter Calabresi Ellen Mowry Michael D Kornberg Elias Sotirchos cell.com/cell-reports-m… 1/2
Peter Calabresi Peter Calabresi of Johns Hopkins Medicine sharing his latest on leveraging iPSCs to model glia and neurotoxicity in multiple sclerosis – including work done in collaboration with our own Valentina Fossati VFossati (she, her) #NYSCF2023
So energized to be with my team Moira Baynes Shuvro Roy, MD Peter Calabresi Johns Hopkins Medicine with National MS Society and great support WTOP Washington Wizards D.C. United Giant Food Leidos KPMG and so many others we will win #BeatMS #SincereThanks
Collaborative work between #MS PATHS MS centres: elevated sNfL is associated with disability, inflammatory activity, and whole brain atrophy in MS, but interpretation needs to account for comorbidities.
Elias Sotirchos Peter Calabresi Cemcat
doi.org/10.1002/acn3.5…
Central vein sign: A diagnostic biomarker in multiple sclerosis sciencedirect.com/science/articl… CAVS-MS U01 study protocol already 1/4 enrolled Daniel Reich Pascal Sati Marwa Kaisey, MD Russell Shinohara Peter Calabresi Ellen Mowry Jeff Cohen QMENTA Cleveland Clinic Cedars-Sinai
Can b-cell therapies (ocrevus, rituximab, kesimpta, briumvi) stop chronic active lesions? Per this study looking at paramagnetic rim lesions on MRI, no. We need new options for progressive MS. Authors include Peter Calabresi and Daniel Reich sciencedirect.com/science/articl…
Glucagon-Like Peptide-1 Receptor Agonist as New Therapeutics for Multiple Sclerosis🎉🎯🌠
Our research highlight is now released!!!!!! Peter Calabresi cdmrp.health.mil/msrp/research_…